Item 2.02. Results of Operations and Financial Condition.

On November 2, 2020, Pacific Biosciences of California, Inc. announced its financial results for its third fiscal quarter ended September 30, 2020. A copy of the press release containing the announcement is attached as Exhibit 99.1 hereto and is incorporated herein by reference.

This information, as well as Exhibit 99.1, is intended to be furnished under Item 2.02 of Form 8-K, "Results of Operations and Financial Condition" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

99.1 Press Release dated November 2, 2020 titled "Pacific Biosciences of

California, Inc. Announces Third Quarter 2020 Financial Results" (furnished

and not filed herewith solely pursuant to Item 2.02).

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)





                                       ?

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses